FyoniBio GmbH

Let us skip long and pompous celebratory texts this time. We just wish you a very Merry Christmas! Enjoy your holidays, and have some fun! With love, FyoniBio GmbH #FyoniBio #Christmas

Well, let’s wrap up this year! 2024 was a challenging and sometimes heartbreaking year, but at FyoniBio GmbH, we are proud to see our company nonetheless continuing to grow. This year, we: ⭐ Gathered together. ⭐ Traveled far and wide. ⭐ Ran marathons. ⭐ Celebrated milestones. ⭐ Overcame obstacles. ⭐ Presented our expertise. ⭐ Connected with you—at conferences, via Zoom, and in-house. ⭐ Listened to you. ⭐ Supported you. Thank you for being with us every step of the way. Let’s achieve even more together in 2025! #FyoniBio #2024

It’s always rewarding to hear praise for our technology and our team’s dedication to quality and seamless communication! At FyoniBio GmbH, we’re always striving to help our customers make a difference. Excited for what’s ahead, Strike Pharma AB!   Looking to make a difference too? Visit our website at https://www.fyonibio.com or reach out directly at [email protected] – we’d be glad to hear from you! #FyoniBio #ClientTestimonial #CellLineDevelopment #ProcessDevelopment

As December is already around the corner and the world starts slowing down towards the Christmas holidays, FyoniBio GmbH would like to conclude this fantastic autumn conference season by extending a heartfelt thank you to everyone we met along the way! Your time, insights, and collaboration have been invaluable. It’s been an inspiring few months, with industry momentum building and exciting conversations sparking new opportunities for growth.   Our Managing Directors reflected on the industry’s steady recovery from post-COVID investment challenges:   "Robust platform technologies have become essential, and this is where FyoniBio stands out. This season, we’ve had countless enriching talks to expand our offerings—especially in MCB preparation—and identify new partners. All in all, referring to a recent Nature Biotechnology article, ‘Biotech financing: darkest before the dawn,’ dawn is on the horizon, and we are in a good position to start the day." — Lars Stöckl   "It’s fantastic to see not only interest in our services but also recognition for our innovative, science-driven approach. Each event offered unique perspectives and stimulating discussions that fuel our commitment to advancing the field." — Hans Baumeister   Thank you again for connecting with us – together, we’re moving biopharma forward! #FyoniBio #Biopharma #Networking

What delivers value and trust, grounded in attention to detail, continuous improvement, and alignment with customer and stakeholder needs? The answer: Quality. Today is the World Quality Day, and FyoniBio GmbH would like you to meet our Director of Quality Management, Hülya Kaplan. She oversees our Quality Management System, ensuring every detail is just right. According to Hülya: "Our QMS is based on the requirements of ISO 9001:2015 and Good Clinical Laboratory Practices. Additionally, we have integrated the core principles shared by GCP, GMP, and GLP guidelines. This approach not only ensures excellent and continuously improved quality and consistency but also upholds the principles of patient safety and data integrity." When you partner with #FyoniBio, you can be confident that quality and integrity are our priorities. #FyoniBio #WorldQualityDay #Quality

#TIDES is on and Hans Baumeister is looking forward to chat with you! Find him in the crowd or drop by his poster – an inspiring and insightful discussion is guaranteed! 12–14 November 2024 Hamburg, Germany #FyoniBio #TIDESEurope #Oligonucleotides

Day 1 at Clinical Outsourcing Group Europe, and FyoniBio GmbH is ready for engaging and exciting discussions! Hans Baumeister and Frederick Gyapon Quast are here to connect, share insights, and explore how we can help accelerate your clinical development projects. Stop by booth #32 and let’s dive into the latest in bioanalytics together! Looking forward to meeting you all! 12–13 November 2024 Amsterdam, The Netherlands   #FyoniBio #COGEurope #clinicaltrials #clinicaldevelopment

Last day of PEGS Europe 2024! Don’t miss Lena Tholen’s insightful talk on innovative cell line development approaches. Join us for a deep dive into cutting-edge solutions that can help accelerate your projects. Let's wrap up this fantastic event together! #FyoniBio #PEGSEurope #CellLineDevelopment #Proteins

FyoniBio’s team is at PEGS Europe 2024! Lena Tholen and Abdullah Karacorluoglu would love to chat about how we can help accelerate your projects. Explore the latest technologies and cutting-edge research with us—swing by our booth #1305. We promise a useful and engaging conversation. 😉 5-7 November, 2024 Barcelona, Spain   #FyoniBio #PEGSEurope #CellLineDevelopment #Proteins

How about catching up with FyoniBio GmbH at BIO-Europe 2024? As a science-driven service provider, we specialize in moving biopharma innovations forward—from cell line and process development to MS-based analytics and clinical bioanalysis. Meet Lars Stöckl, Hans Baumeister, and Frederick Gyapon Quast at our bright new booth #23! Let’s discuss how we can help guide your project from concept to clinic. Whether you’re a researcher, business development professional, or investor, we look forward to connecting with you! 4–6 November 2024 Stockholm, Sweden #FyoniBio #BIOEurope2024 #CellLineDevelopment #Biologics